4//SEC Filing
Ward Robert 4
Accession 0001415889-19-000399
CIK 0001035354other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:15 PM ET
Size
9.6 KB
Accession
0001415889-19-000399
Insider Transaction Report
Form 4
Ward Robert
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2019-03-26+35,599→ 131,156 total - Tax Payment
Common Stock
2019-03-26$11.50/sh−10,467$120,371→ 120,689 total - Exercise/Conversion
Restricted Stock Units
2019-03-26−35,599→ 391,591 total→ Common Stock (35,599 underlying)
Footnotes (6)
- [F1]The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock.
- [F2]Of this amount, 116,156 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee.
- [F3]Of this amount, 105,689 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan.
- [F6]The remaining restricted stock units will vest ratably each quarter through December 26, 2021 subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001595111
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:15 PM ET
- Size
- 9.6 KB